Pharvaris plans $7M sale of 200,000 shares

Amended Form 144 for Pharvaris N.V. updates insider share sale details, including a June 30, 2026 trade and a new 200,000-share planned sale.

Rhea-AI Filing Summary

Pharvaris N.V. (PHVS) is named as the issuer in an amended Form 144 notice covering planned sales of 200,000 shares of common stock for the account of Johannes Gerardus Christiaan Petrus Schikan. The shares are to be sold through Morgan Stanley Smith Barney LLC, with an aggregate market value of $7,000,000, and Pharvaris reports 65,210,590 common shares outstanding as of September 17, 2026.

The securities to be sold were acquired on December 23, 2015 as founder stock from the issuer for cash. Over the past three months, Schikan has sold Pharvaris common shares in several transactions, including 30,712 shares for $1,090,048.73 on June 30, 2026. The amendment states it is being filed to update the amount of securities sold and gross proceeds for the June 30, 2026 trade.

Key Figures

Shares to be sold: 200,000 shares Aggregate market value of planned sale: $7,000,000 Shares outstanding: 65,210,590 shares +4 more

7 metrics

Shares to be sold 200,000 shares Planned sale of Pharvaris common stock for Schikan under Form 144

Aggregate market value of planned sale $7,000,000 Estimated market value for the 200,000 shares to be sold

Shares outstanding 65,210,590 shares Pharvaris common shares outstanding as of September 17, 2026

Sale on June 30, 2026 30,712 shares for $1,090,048.73 Pharvaris common stock sold by Schikan during the past 3 months

Sale on June 29, 2026 (1) 6,888 shares for $241,424.40 Pharvaris common stock sold by Schikan during the past 3 months

Sale on June 29, 2026 (2) 2,400 shares for $84,240.00 Additional Pharvaris common stock sale by Schikan

Acquisition date of founder stock December 23, 2015 Date Schikan acquired founder stock from Pharvaris for cash

Key Terms

Rule 144, Founder Stock, aggregate market value

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Founder Stock financial

"Common | 12/23/2015 | Founder Stock | Issuer |"

aggregate market value financial

"Common | Morgan Stanley Smith Barney LLC ... | 200000 | 7000000.00 |"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Pharvaris N.V. (PHVS) disclose in this amended Form 144?

The filing reports that 200,000 Pharvaris common shares held for Johannes Gerardus Christiaan Petrus Schikan are planned for sale through Morgan Stanley Smith Barney LLC, with an aggregate market value of $7,000,000, and updates prior sale data for June 30, 2026.

How many Pharvaris (PHVS) shares are planned to be sold under this Form 144/A?

The notice covers a proposed sale of 200,000 shares of Pharvaris common stock. These shares are associated with Johannes Gerardus Christiaan Petrus Schikan and are to be sold through Morgan Stanley Smith Barney LLC under Rule 144.

What past Pharvaris (PHVS) share sales by Schikan are disclosed in the last 3 months?

The filing lists three common stock sales: 30,712 shares for $1,090,048.73 on June 30, 2026, 6,888 shares for $241,424.40 on June 29, 2026, and 2,400 shares for $84,240.00 on June 29, 2026.

What specific change does this Form 144/A amendment make for Pharvaris (PHVS)?

The amendment states it is filed to amend the amount of securities sold and gross proceeds for the trade completed on June 30, 2026, updating the disclosed share count and dollar proceeds for that transaction.

How many Pharvaris (PHVS) shares are reported outstanding in this filing?

The filing reports 65,210,590 Pharvaris common shares outstanding as of September 17, 2026. This figure provides context for the relative size of the planned 200,000-share sale under the Form 144 notice.

When and how were the Pharvaris (PHVS) shares to be sold originally acquired?

The securities to be sold are identified as Founder Stock acquired from the issuer on December 23, 2015 for cash. The source is listed as the issuer, Pharvaris N.V.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 09/22/2026 - 04:19 PM Accepted by SEC EDGAR 09/22/2026 - 04:18 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144/A

144/A: Filer Information

Filer CIK	0002014983
Filer CCC	XXXXXXXX
Previous Accession Number Of The Filing	0001950047-26-009654
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144/A: Issuer Information

Name of Issuer	PHARVARIS N.V.
SEC File Number	001-40010
Address of Issuer	Emmy Noetherweg 2 Leiden NETHERLANDS 2333 BK
Phone	31 (0)71 2036 410
Name of Person for Whose Account the Securities are To Be Sold	JOHANNES GER. CHRIS. PE SCHIKAN
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer
Relationship to Issuer	Director

144/A: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	200000	7000000.00	65210590	09/17/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144/A: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	12/23/2015	Founder Stock	Issuer			200000	12/23/2015	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144/A: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
JOHANNES GER. CHRIS. PE SCHIKAN Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/30/2026	30712	1090048.73
JOHANNES GER. CHRIS. PE SCHIKAN Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/29/2026	6888	241424.40
JOHANNES GER. CHRIS. PE SCHIKAN Emmy Noetherweg 2 Leiden P7 2333 BK	Common	06/29/2026	2400	84240.00

144/A: Remarks and Signature

Remarks	This Form 144/A is being filed to amend Amount of Securities Sold and Gross Proceeds for trade completed on 06/30/2026.
Date of Notice	09/22/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Johannes Gerardus Christiaan Petrus Schikan
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)